0001012975-15-000648.txt : 20150819
0001012975-15-000648.hdr.sgml : 20150819
20150819163453
ACCESSION NUMBER: 0001012975-15-000648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150817
FILED AS OF DATE: 20150819
DATE AS OF CHANGE: 20150819
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STARR KEVIN P
CENTRAL INDEX KEY: 0001192603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 151064429
MAIL ADDRESS:
STREET 1: 75 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-17
0001629137
Global Blood Therapeutics, Inc.
GBT
0001192603
STARR KEVIN P
C/O GLOBAL BLOOD THERAPEUTICS, INC.
400 EAST JAMIE COURT, SUITE 101
SOUTH SAN FRANCISCO
CA
94080
1
0
1
0
Common Stock
2015-08-17
4
C
0
11903763
A
12475191
I
By Third Rock Ventures II, L.P.
Common Stock
2015-08-17
4
C
0
2285713
A
2285713
I
By Third Rock Ventures III, L.P.
Series A Preferred Stock
2015-08-17
4
C
0
41663168
0
D
Common Stock
11903763
0
I
By Third Rock Ventures II, L.P.
Series A Preferred Stock
2015-08-17
4
C
0
8000000
0
D
Common Stock
2285713
0
I
By Third Rock Ventures III, L.P.
The aggregate number of shares of Issuer's Preferred Stock held by the Reporting Person converted into Common Stock immediately prior to the closing of the Issuer's initial public offering and has no expiration date. These shares converted into Common Stock on a 3.5-for-1 basis.
Reflects the conversion of the Issuer's Preferred Stock into Common Stock on a 3.5-for-1 basis, which became effective immediately prior to the closing of the Issuer's initial public offering.
The shares are directly held by Third Rock Ventures II, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP II, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP II, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper") and, as such, each of TRV GP, TRV GP LLC, Levin, Starr and Tepper exercises shared voting and investment power over the shares held of record by TRV. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
The shares are directly held by Third Rock Ventures III, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP III, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP III, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper") and, as such, each of TRV GP, TRV GP LLC, Levin, Starr and Tepper exercises shared voting and investment power over the shares held of record by TRV. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any
Kevin Gillis by power of attorney for Kevin Starr
2015-08-19